Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA
- PMID: 30593563
- PMCID: PMC6329986
- DOI: 10.1073/pnas.1815031116
Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA
Abstract
Circulating DNA in plasma consists of short DNA fragments. The biological processes generating such fragments are not well understood. DNASE1L3 is a secreted DNASE1-like nuclease capable of digesting DNA in chromatin, and its absence causes anti-DNA responses and autoimmunity in humans and mice. We found that the deletion of Dnase1l3 in mice resulted in aberrations in the fragmentation of plasma DNA. Such aberrations included an increase in short DNA molecules below 120 bp, which was positively correlated with anti-DNA antibody levels. We also observed an increase in long, multinucleosomal DNA molecules and decreased frequencies of the most common end motifs found in plasma DNA. These aberrations were independent of anti-DNA response, suggesting that they represented a primary effect of DNASE1L3 loss. Pregnant Dnase1l3-/- mice carrying Dnase1l3+/- fetuses showed a partial restoration of normal frequencies of plasma DNA end motifs, suggesting that DNASE1L3 from Dnase1l3-proficient fetuses could enter maternal systemic circulation and affect both fetal and maternal DNA fragmentation in a systemic as well as local manner. However, the observed shortening of circulating fetal DNA relative to maternal DNA was not affected by the deletion of Dnase1l3 Collectively, our findings demonstrate that DNASE1L3 plays a role in circulating plasma DNA homeostasis by enhancing fragmentation and influencing end-motif frequencies. These results support a distinct role of DNASE1L3 as a regulator of the physical form and availability of cell-free DNA and may have important implications for the mechanism whereby this enzyme prevents autoimmunity.
Keywords: cell-free DNA; cfDNA; liquid biopsy; noninvasive prenatal testing; systemic lupus erythematosus.
Copyright © 2019 the Author(s). Published by PNAS.
Conflict of interest statement
Conflict of interest statement: Y.M.D.L. is a scientific cofounder and a member of the scientific advisory board for Grail. Y.M.D.L., R.W.K.C., and K.C.A.C. hold equity in Grail and receive research funding from Grail/Cirina for other projects. Y.M.D.L., R.W.K.C., K.C.A.C., and P.J. are consultants to Grail. Y.M.D.L., R.W.K.C., and K.C.A.C. are cofounders and board members of DRA Company Limited. Y.M.D.L., R.W.Y.C., R.W.K.C., K.C.A.C., P.J., L.S., and B.R. plan to file a patent application based on the data generated from this work.
Figures
References
-
- Lo YMD, et al. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350:485–487. - PubMed
-
- Chan KCA, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377:513–522. - PubMed
-
- Lo YMD, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med. 2010;2:61ra91. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
